Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.7377
+0.0295 (4.17%)
At close: Apr 27, 2026, 4:00 PM EDT
0.7126
-0.0251 (-3.40%)
After-hours: Apr 27, 2026, 7:48 PM EDT
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $17.4 million as of April 27, 2026. Its market cap has decreased by -73.64% in one year.
Market Cap
17.40M
Enterprise Value
-6.72M
1-Year Change
-73.64%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $17.40M, a decrease of -91.66%. That is a compound annual growth rate of -43.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 16.71M | -52.15% |
| Dec 31, 2025 | 34.91M | -56.12% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Passage Bio | 18.73M |
| Psyence Biomedical | 18.14M |
| Lipocine | 17.67M |
| Theriva Biologics | 17.49M |
| Citius Pharmaceuticals | 17.23M |
| Pasithea Therapeutics | 17.21M |
| Cadrenal Therapeutics | 16.93M |
| SeaStar Medical Holding | 16.49M |